Allgemein

Gedeon Richter receives “The Most Innovative Product” award from gynaecologists for Ryeqo® and is ranked second in the Pharma Trend Ranking 2022

The specialist group of gynaecologists awards Gedeon Richter 2022 for its preparation Ryeqo® with the award “The most innovative product”. In the interdisciplinary ranking “Best Pharmaceutical Companies in Germany”, Gedeon Richter moves up 5 places in the category “Large individual, medium-sized and international companies” in 2022 and takes 2nd place. InfectoPharm was ranked first and … [Read more…]

BioNTech wins the “Golden Tablet” of general practitioners, receives the award “The Most Innovative Product” twice for Comirnaty® and places 6th in the Pharma Trend Ranking 2022

BioNTech wins the “Golden Tablet of General Practitioners, Practitioners and Internists (APIs) in Pharma Trend 2022, repeating its success from the previous year. The “APIs” as well as the paediatricians’ specialist group also give the company the award “The Most Innovative Product” for its COVID vaccine Comirnaty®. BioNTech thus places 6th in the inter-specialist “Best … [Read more…]

Astellas ranks 10th in Pharma Trend Ranking 2022

In the multispecialty ranking “Best Pharmaceutical Companies Germany” 2022, Astellas comes in 10th place in the category “research-based, world-leading pharmaceutical companies by sales”. The first places in the category go to Janssen-Cilag, Novartis and Bayer Vital/Jenapharm. Astellas has long been one of the market leaders in Germany in the therapeutic fields of urology and transplant … [Read more…]

Bionorica ranks second in the Pharma Trend Ranking 2020

Bionorica is ranked second in the multidisciplinary ranking “Best Pharmaceutical Companies Germany” 2020 in the category “Large individual, medium-sized and international companies”. In addition, Bionorica wins the pharmacists’ award “The Golden Tablet” in the OTC category.

Dr. Falk Pharma ranks 4th in the Pharma Trend Ranking 2020

Dr. Falk Pharma is ranked 4th in the multidisciplinary ranking “Best Pharmaceutical Companies Germany” 2020 in the category “Large individual, medium-sized and international companies”. In Pharma Trend, Dr. Falk Pharma was recognised for innovation for the last time in 2018 with Jorveza®, which was awarded “The Most Innovative Product” by gastroenterologists in the OD category.

Grünenthal ranks 10th in Pharma Trend Ranking 2020

Grünenthal is ranked 10th in the multispecialty ranking “Best Pharmaceutical Companies Germany” 2020 in the category “Large Individual, Medium-sized and International Companies”. In Pharma Trend, Grünenthal was awarded for innovation for the first time in 2020 with Palexia®, which received the award “The Most Innovative Product” in the Rx category from pain therapists.

High-performance Liquid Chromatography (HPLC) Market 2019-2023 | Evolving Opportunities with Agilent Technologies, Inc. and GE Healthcare | Technavio

LONDON–(BUSINESS WIRE)–#HPLC–Technavio has been monitoring the global high-performance liquid chromatography (HPLC) market since 2016 and the market is poised to grow by USD 1.05 billion during 2019-2023, progressing at a CAGR of almost 5% during the forecast period. Request Free Sample Pages Read the 125-page research report with TOC on “High-performance Liquid Chromatography (HPLC) Market … [Read more…]

Perspectum announces partnership with Precious Medical Centre

For the first time in Asia, non-invasive assessment of liver tissue health with LiverMultiScan is available clinically at Precious Medical Centre in Singapore LiverMultiScan quantifies liver fat, iron and fibro-inflammation; providing additional insight to support management of chronic liver disease patients and potentially reduce the need for painful biopsies SINGAPORE–(BUSINESS WIRE)–Perspectum, the leading provider of … [Read more…]

Mundipharma: Swissmedic reviewing licence extension for the SGLT2 inhibitor Invokana® (canagliflozin) in fast-track procedure

Swissmedic is currently conducting a fast-track review of an application to extend marketing authorisation for Invokana® (canagliflozin) to the treatment of patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). The CREDENCE renal outcomes study, which was stopped early in July 2018 owing to positive efficacy findings, served as the basis for … [Read more…]

Growth of E-Nose Market to be Impacted by the Development of E-Nose Chips that can be Integrated into Smartphones | Technavio

The market will accelerate at a CAGR of 10.67% between 2019-2023 LONDON–(BUSINESS WIRE)–#_EnviroSuite–The report, e-nose market 2019-2023, has been added to Technavio’s catalog. It provides a comprehensive analysis of the market, including its global and regional market share as well as market segmentation based on end-user (environmental monitoring, food and beverage, healthcare, and others) and … [Read more…]